SCHEMBL8809581

SCHEMBL8809581

COc1ccc(CCNCCOc2ccc(NC(=O)c3cc(-c4ccccc4)nc4ccc(C)cc34)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.60
▸ CA12 O43570 2/20 0.55
▸ CA1 P00915 2/20 0.55
▸ CA2 P00918 2/20 0.55
▸ CA9 Q16790 2/20 0.55
▸ TACR3 P29371 2/20 0.54
▸ TP53 P04637 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ DHODH Q02127 1/20 0.53
▸ MAPT P10636 4/20 0.53
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ KDM4E B2RXH2 4/20 0.52
▸ POLB P06746 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ PTPN7 P35236 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ DUSP3 P51452 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8807581 0.94 CYP3A4 (0.63) CYP3A4CA12CA1CA2CA9
SCHEMBL8809571 0.85 CYP3A4 (0.59) CYP3A4CA12CA1CA2CA9
SCHEMBL8807576 0.79 CYP3A4 (0.62) CYP3A4CA12CA1CA2CA9
SCHEMBL13253428 0.79 MEN1 (0.66) CYP3A4CA12CA1CA2CA9
SCHEMBL13912444 0.77 CYP3A4 (0.77) CYP3A4CA12CA1CA2CA9
SCHEMBL8808332 0.76 MEN1 (0.52) CYP3A4LMNAMAPTMEN1KMT2A
SCHEMBL13253440 0.75 CYP3A4 (0.65) CYP3A4CA12CA1CA2CA9
SCHEMBL13253423 0.75 KMT2A (0.84) CYP3A4CA12CA1CA2CA9
SCHEMBL13253448 0.74 MEN1 (0.73) CYP3A4CA12CA1CA2CA9
SCHEMBL28844500 0.74 TACR3 (0.76) CYP3A4CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback